Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Operating Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Operating Profit (Excl OI) ₹30 Cr₹20 Cr₹20 Cr₹1,655,282 Cr₹17 Cr

What is the latest Operating Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Operating Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹30 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹30 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,655,282 Cr
Mar2017₹17 Cr

How is Operating Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Operating Profit % Change
Mar2025 ₹30 Cr
48.98
Mar2024 ₹20 Cr
-0.67
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,655,282 Cr
9,930,201.10
Mar2017 ₹17 Cr -

Compare Operating Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,426.9 Cr -1.2% -5.8% -33.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,170.0 Cr -1.6% 4.6% -0.8% Stock Analytics
DIVIS LABORATORIES ₹167,038.0 Cr -2.5% -6% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,357.0 Cr 1.2% -1.4% 11.8% Stock Analytics
CIPLA ₹120,414.0 Cr -1.2% -1.5% -0.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,015.0 Cr -2.7% 4% 2.2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-1.2%

-5.8%

-33.3%

SENSEX

-0.6%

1.7%

4.6%


You may also like the below Video Courses